Nuance Investments, LLC Nuvasive Inc Transaction History

Nuance Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$36.71 - $44.15 $42,032 - $50,551	1,145 Added 0.41%	281,023 $11.7 Million
Q1 2023 May 09, 2023	BUY	$36.81 - $48.12 $216,479 - $282,993	5,881 Added 2.15%	279,878 $11.6 Million
Q4 2022 Feb 07, 2023	SELL	$35.68 - $44.71 $394,228 - $494,000	-11,049 Reduced 3.88%	273,997 $11.3 Million
Q3 2022 Nov 10, 2022	BUY	$42.51 - $54.02 $643,856 - $818,186	15,146 Added 5.61%	285,046 $12.5 Million
Q2 2022 Aug 08, 2022	SELL	$46.84 - $59.75 $5.61 Million - $7.16 Million	-119,851 Reduced 30.75%	269,900 $13.3 Million

Q1 2022 May 13, 2022	BUY	$48.09 - $57.79 $18.7 Million - $22.5 Million	389,751 New	389,751 $22.1 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Nuance Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuance Investments, LLC with notifications on news.